Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans

Mycopathologia

Volumn 159, Issue 4, 2005, Pages 501-507

  Consolaro, M E L ^a   Albertoni, T A ^a   Svidzinski, A E ^a   Peralta, R M ^a   Svidzinski, T I E ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Antifungal agents; Candida albicans; Germ tube; Vulvovaginal candidiasis

Indexed keywords

ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; FEMALE; FUNGUS HYPHAE; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; VAGINA CANDIDIASIS;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; HYPHAE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

CANDIDA ALBICANS;

EID: 21144432445     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-005-1149-0     Document Type: Article

References (28)

1. GB Ziarrusta 2001 Vulvovaginitis candidiásica Rev Iberoam Micol 19 22 24
2. JD Sobel 1993 Candidal vulvovaginitis Clin Obstet Gynecol 36 153 212
3. WL Chaffin JL López-Ribot M Casanova D Gozalbo JP Martínez 1998 Cell wall and secreted proteins of Candida albicans: Identification, function, and expression Microbiol Mol Biol Rev 62 130 180
4. KA Hammer CF Carson TV Riley 2000 Malaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans Med Mycol 38 355 362
5. FC Odds CE Webster P Mayuranathan PD Simmons 1988 Candida concentrations in the vagina and their association with signs and symptoms. of vaginal candidosis J Med Vet Mycol 26 277 283
6. H Lo JR Köhler B Didornenico D Loebenberg A Cacciapuoti GR Fink 1997 Nonfilatnentous C. albicans mutants are avirulent Cell 90 939 949
7. JD Sobel 1996 Fungal diseases in genitourinary medicine CC Kibbler DWR Mackenzie FC Odds Principles and Pratice of Clinical Mycology Wiley England 179 199
8. JD Sobel W Chaim 1997 Treatment of Torulopsis glabrata vaginitis: Retrospective review of boric acid therapy Clin Infect Dis 24 649 652
9. IB Enwani HC Gugnani R Okobia SB Ojo 2001 Effect of contraceptives on the prevalence of vaginal colonization with Candida species in Edo State Nigeria. Rev Iberoam Micol 18 171 173
10. DH Larone 1995 Medically Important Fungi. A Guide to Identification AMS Press Washington
11. CP Kurtzman JW Fell 1998 The Yeast. A Taxonomic Study Elsevier Amsterdam
12. T Sugita S Kurosaka M Yajitate H Sato A Nishikawa 2002 Extracellular proteinase and phospholipase activity of three genotypic strains of a human pathogenic yeast, Candida albicans Microbiol Immunol 46 881 883
13. Consolaro MEL, Albertoni TA, Yoshida CS, Mazucheli Peralta RM, Sviszinski TIE. Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringá, Paraná, Brazil. Rev Iberoam Micol 2004; 21: 202-205
14. MMS Vilela K Kamei A Sano R Tanaka J Uno I Takahashi J Ito K Yarita M Miyji 2002 Pathogenicity and virulence of Candida dubliniensis: Comparison with C. albicans Med Mycol 40 249 257
15. National Committee for Clinical Laboratory Standards (NCCLS). Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Wayne PA NCCLS 1997; 17: 1-8
16. JD Sobel G Muller HR Buckley 1984 Critical role of germ tube formation in the pathogenesis of candidal vaginitis Infect Immun 44 576 580
17. T Akashi T Kanbe K. Tanaka 1994 The role of the cytoskeleton in the polarized growth of the germ tube in Candida albicans Microbiology 140 271 280
18. A Felk M Kretschmar A Albrecht M Schaller S Beinhauer T Nichterlein D Sanglard HC Korting W Schafer B Hube 2002 Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap 4 to Sap 6 are required for the invasion of parenchymal organs Infect Immun 70 3689 3700
19. JM Jones 1990 Laboratory diagnosis of invasive candidiasis Clin Microbiol Rev 3 32 45
20. PL Fidel Jr JD Sobel 1996 Immunopathogenesis of recurrent vulvovaginal candidiasis Rev Clin Microbiol 9 335 348
21. A Duerr MF Sierra J Feldman LM Clarke I Ehrlich J DeHovitz 1997 Immune compromised and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women Obst Gynecol 90 252 256
22. B Hube D Hess CA Baker M Schaller W Schäfer W Dolan 2001 The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans Microbiology 147 879 889
23. Y Imanishi K Yokoyama K Nishimura 2004 Inductions of germ tube hyphal formation are controlled by mRNA synthesis inhibitor in Candida albicans Jpn J Med Mycol 45 113 119
24. MA Ribeiro R Dietze CR Paula DA Matta AL. Colombo 2000 Susceptibility profile of vaginal yeasts isolates from Brazil Mycopathologia 151 5 10
25. Sobel JD.Vulvovaginitis due to Candida glabrata. An emerging problem. Mycoses 1998 (supp12):18-22
26. ME Lynch JD Sobel PL Fidel Jr 2000 Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis J Med Vet Mycol 34 337 339
27. PL Fidel Jr KA Ginsburg JL Cutright NA Wolf D Leoman K Dunlap JD Sobel 1997 Vaginal-associated immunity in woman with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen J Clin Infect Dis 176 728 739
28. PL Fidel Jr JA Vasquez JD Sobel 1999 Candida glabrata, review of epidemiology, pathogenesis and clinical disease with comparison to Candida albicans Clin Microbiol Rev 12 80 96